A novel drug response score more accurately predicts renoprotective drug effects than existing renal risk scores
Background: Risk factor-based equations are used to predict risk of kidney disease progression in patients with type 2 diabetes order to guide treatment decisions. It is, however, unknown whether these models can also be used to predict the effects of drugs on clinical outcomes. Methods: The previou...
Main Authors: | Nienke M. A. Idzerda, Sok Cin Tye, Dick de Zeeuw, Hiddo J. L. Heerspink |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-02-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018820974191 |
Similar Items
-
Is chronic dialysis the right hard renal end point to evaluate renoprotective drug effects?
by: Weldegiorgis, M, et al.
Published: (2017) -
Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
by: Sok Cin Tye, et al.
Published: (2022-01-01) -
The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.
by: Bauke Schievink, et al.
Published: (2014-01-01) -
Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?
by: Gozewijn D Laverman, et al.
Published: (2002-12-01) -
Accountability Is More Than a Test Score
by: Stephan Turnipseed, et al.
Published: (2015-02-01)